Previous studies revealed that the complete loss of TβRII tissue expression in breast cancers was associated with the development of distant metastases and poor overall survival, and absence of TβRII in carcinoma cells promotes mammary tumor growth [9,11]. Here, TGFBR2 is linked to carcinoma.